OT"The Minimal Impact of a Big Hypertension Study | Arthritis Information

Share
 

http://www.nytimes.com/2008/11/28/business/28govtest.html?pagewanted=1&_r=1&sq=diuretics&st=cse&scp=1

From the NY Times article:

Dr. Sean Tunis, a former chief medical officer for Medicare, remains an advocate for comparative-effectiveness studies. But, as Allhat showed, “they are hard to do, expensive to do and provoke a lot of political pushback,” said Dr. Tunis, who now runs the nonprofit Center for Medical Technology Policy, which tries to arrange such trials.

“There’s a lot of magical thinking,” he said, “that it will all be science and won’t be politics.”


Maybe we will see more comparative-effectiveness studies as the government gets more involved in healthcare?
Suzanne2008-12-06 08:45:48Sometimes the "old way" is the "best Way"
 
Thanks for the Info.
 

Copyright ArthritisInsight.com